| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 1.113 | 48.865 | 152.832 | 343.717 | 869.390 | 1.523.489 | 2.063.157 | 454.983 | 21.962 |
| Total Income - EUR | 0 | 1.113 | 48.865 | 152.832 | 343.717 | 869.390 | 1.523.570 | 2.063.180 | 454.983 | 22.823 |
| Total Expenses - EUR | 438 | 802 | 47.662 | 133.866 | 307.541 | 654.477 | 1.377.075 | 1.932.224 | 419.388 | 46.843 |
| Gross Profit/Loss - EUR | -438 | 311 | 1.203 | 18.966 | 36.176 | 214.913 | 146.495 | 130.956 | 35.595 | -24.019 |
| Net Profit/Loss - EUR | -438 | 300 | 714 | 17.438 | 32.579 | 206.174 | 128.910 | 115.787 | 30.749 | -24.019 |
| Employees | 0 | 1 | 3 | 3 | 4 | 3 | 4 | 6 | 2 | 1 |
Check the financial reports for the company - Mirela Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.929 | 17.731 | 799 |
| Current Assets | 1.594 | 1.911 | 22.840 | 82.091 | 133.061 | 605.275 | 1.066.552 | 1.469.922 | 643.740 | 596.391 |
| Inventories | 0 | 0 | 2.839 | 4.716 | 12.686 | 480 | 93.464 | 180.561 | 0 | 0 |
| Receivables | 1.594 | 1.800 | 19.162 | 74.588 | 120.101 | 604.150 | 972.825 | 1.288.706 | 640.526 | 596.364 |
| Cash | 0 | 111 | 840 | 2.787 | 275 | 645 | 264 | 655 | 3.214 | 27 |
| Shareholders Funds | -10.613 | -10.205 | -9.319 | 7.589 | 42.860 | 247.967 | 371.378 | 488.317 | 263.375 | 234.199 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.207 | 12.116 | 32.159 | 74.502 | 90.202 | 357.308 | 695.174 | 1.004.534 | 398.096 | 362.990 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Mirela Pharm Srl